Oliceridine (Olinvyk) expands options for managing moderate to severe acute pain, but cost, drug-drug interactions, and other factors come into play.
Himayapsill Batista Quevedo, PharmD
Advertisement
Articles by Himayapsill Batista Quevedo, PharmD
Peripherally acting M-opioid receptor antagonists can improve quality of life but differ variably by impact from concomitant medications.
Advertisement
Latest Updated Articles
Toxicity Is a Risk of PAMORA InteractionsJuly 1st 2020
Pharmacists Can Help Assess New FDA-Approved IV OpioidNovember 20th 2020
Advertisement
Advertisement
Trending on Pharmacy Times
1
Staging the Heart: NLA and EAS Reveal a New Era of Precision Lipidology and Imaging
2
Orforglipron Reduces Body Weight Up to 14% in Women at Every Stage of Menopause
3
New Evidence Positions Finerenone as Foundational Therapy Across the CKD Spectrum
4
Final CLL14 Analysis Confirms Durable Benefit With Fixed-Duration Venetoclax-Obinutuzumab in Frontline CLL
5